Nhan Van Do, MD

Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Nhan Van Do is an Associate Professor of Medicine at BUSM and the Director of the Informatics Center at the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). Dr. Do completed his training in Biomedical Informatics at Stanford University. After his Informatics training and prior to joining the VA and the faculty at BU, he had served in several informatics leadership positions in the Military Health System such as Chief Medical Information Officer and Medical Informatics Consultant to Surgeon General to manage and support the design, development, implementation, and evaluation of health information technology. In his current position as the Informatics Center Director, he is responsible for developing the computing infrastructure to support the VA’s Research Precision Oncology program and Point of Care Research. His research interests also include clinical decision support and predictive analytics.

Publications

  • Published 5/8/2023

    Placido D, Yuan B, Hjaltelin JX, Zheng C, Haue AD, Chmura PJ, Yuan C, Kim J, Umeton R, Antell G, Chowdhury A, Franz A, Brais L, Andrews E, Marks DS, Regev A, Ayandeh S, Brophy MT, Do NV, Kraft P, Wolpin BM, Rosenthal MH, Fillmore NR, Brunak S, Sander C. A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nat Med. 2023 May; 29(5):1113-1122. PMID: 37156936.

    Read at: PubMed

  • Published 3/1/2023

    Ganti AK, Fillmore NR, Bihn J, La J, Brophy MT, Do NV, Kelley M. Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients. Int J Clin Oncol. 2023 Apr; 28(4):531-542. PMID: 36859565.

    Read at: PubMed

  • Published 1/25/2023

    Elbers DC, La J, Minot JR, Gramling R, Brophy MT, Do NV, Fillmore NR, Dodds PS, Danforth CM. Sentiment analysis of medical record notes for lung cancer patients at the Department of Veterans Affairs. PLoS One. 2023; 18(1):e0280931. PMID: 36696437.

    Read at: PubMed

  • Published 1/10/2023

    Li A, La J, May SB, Guffey D, da Costa WL, Amos CI, Bandyo R, Milner EM, Kurian KM, Chen DCR, Do NV, Granada C, Riaz N, Brophy MT, Chitalia V, Gaziano JM, Garcia DA, Carrier M, Flowers CR, Zakai NA, Fillmore NR. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. J Clin Oncol. 2023 Jun 01; 41(16):2926-2938. PMID: 36626707.

    Read at: PubMed

  • Published 12/14/2022

    La J, Fillmore NR, Do NV, Brophy M, Monach PA, Branch-Elliman W. Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigation. Health Res Policy Syst. 2022 Dec 14; 20(1):134. PMID: 36517793.

    Read at: PubMed

Education

  • George Washington University School of Medicine, MD
  • Stanford University, MS
  • Baylor University, BS